text
"['\n1. 요약재무정보\n가. 요약연결재무정보※ 당사는 당반기 중 삼성바이오에피스㈜를 연결대상 종속기업으로 신규 편입하여, 제12기 반기 연결재무제표부터 해당 종속기업의 연결 편입 이후 재무정보가 포함되었습니다.\r\n(단위 : 백만원)\n구분\n2022년 반기(제12기 반기)\n2021년(제11기)\n2020년(제10기)\n회계처리기준\nK-IFRS\nK-IFRS\nK-IFRS\n연결재무제표\n연결재무제표\n연결재무제표\n[유동자산]\n\xa0 6,344,592\n2,823,175\n1,751,347\n현금및현금성자산\n\xa0 \xa0 \xa0 \xa0 \xa0213,005\n47,410\n28,850\n단기금융상품\n\xa0 \xa0 \xa0 \xa0 1,182,929\n450,000\n300,000\n당기손익-공정가치측정금융자산\n\xa0 \xa0 \xa01,751,492\n850,040\n500,046\n매출채권및기타채권\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0684,002\n366,331\n217,932\n재고자산\n\xa0 \xa0 \xa0 \xa0 2,306,427\n1,012,871\n645,960\n기타유동금융자산\n\xa0 \xa0 \xa0 \xa0 \xa0 42,839\n23,985\n23,556\n기타유동자산\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa079,147\n8,627\n7,138\n계약자산\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 84,751\n63,911\n27,865\n[비유동자산]\n\xa09,314,850\n5,146,836\n4,672,854\n장기금융상품\n\xa0 \xa0 \xa0 \xa0 7,214\n190\n174\n관계기업및공동기업투자\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa018,383\n2,661,309\n2,634,428\n투자부동산\n-\n-\n20,248\n유형자산\n\xa0 \xa02,868,602\n2,207,064\n1,736,567\n무형자산\n\xa05,989,412\n32,172\n23,345\n사용권자산\n\xa0 \xa0 18,528\n20,624\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa024,160\n매출채권및기타채권\n\xa0 \xa0 12,875\n4,428\n\xa0 \xa0 28,672\n순확정급여자산\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0-\n3,572\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 11,900\n기타비유동금융자산\n\xa0 \xa0 \xa0 \xa038,758\n26,919\n23,184\n기타비유동자산\n\xa0 \xa0 \xa0 \xa0 \xa03,469\n1,227\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa01,284\n계약자산\n\xa0 \xa0 \xa0 \xa0 \xa0167,351\n189,331\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0168,892\n당기손익-공정가치측정금융자산\n\xa0 \xa0 \xa0 \xa0 \xa04,114\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0-\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 -\n이연법인세자산\n\xa0 \xa0 \xa0 \xa0 \xa0 186,144\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0-\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0-\n\xa0 \xa0 \xa0 \xa0 자산총계\n\xa0 \xa0 \xa015,659,442\xa0\n7,970,011\n\xa0 \xa0 \xa0 \xa0 \xa0 6,424,201\n[유동부채]\n3,467,676\xa0\n1,107,295\n\xa0 \xa0 \xa0 \xa0589,301\n[비유동부채]\n3,711,884\xa0\n1,871,614\n\xa0 1,236,117\n\xa0 \xa0 \xa0 \xa0 부채총계\n7,179,560\xa0\n2,978,909\n\xa0 \xa0 \xa0 \xa0 1,825,418\n[지배기업 소유주지분]\n\xa0 \xa0 \xa0 \xa08,479,882\n4,991,102\n\xa0 \xa0 \xa04,598,783\n\xa0자본금\n177,935\n165,413\n\xa0 \xa0165,413\n\xa0자본잉여금\n\xa0 \xa0 \xa0 \xa0 \xa0 5,663,111\n2,487,313\n\xa0 \xa0 \xa0 \xa0 \xa02,487,313\n\xa0기타포괄손익누계액\n(7,692)\n(8,811)\n(7,540)\n\xa0이익잉여금\n\xa0 2,646,528\n2,347,187\n\xa0 \xa0 \xa0 \xa0 \xa01,953,597\n[비지배지분]\n\xa0-\n\u3000 -\n\xa0-\n\xa0 \xa0 \xa0 \xa0자본총계\n8,479,882\xa0\n4,991,102\n\xa0 \xa0 \xa0 \xa0 4,598,783\n기간\n2022년 1월~6월\n2021년 1월~12월\n2020년 1월~12월\n\xa0매출액\n1,162,727\n1,568,007\n\xa0 \xa0 \xa0 \xa0 \xa01,164,777\n\xa0영업이익\n346,090\n537,309\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0292,787\n\xa0법인세비용차감전이익\n412,990\n561,283\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0265,992\n\xa0연결총반기순이익\n298,983\n393,589\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0240,975\n\xa0지배기업 소유주지분\n298,983\n393,589\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0240,975\n\xa0비지배지분\n\xa0-\n\xa0-\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0-\n\xa0기본주당순이익 (원)\n4,378\n5,949\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa03,642\n\xa0희석주당순이익 (원)\n4,370\n5,949\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa03,642\n\xa0연결에 포함된 회사수\n14개\n1개\n1개\n나. 요약별도재무정보※ 당사는 제10기(전전기) 중 종속기업이 설립됨에 따라, 2020년 1월 1일 이후 \xa0 \xa0개시하는 보고기간부터 별도재무제표를 작성하게 되었습니다.\xa0\r\n(단위 : 백만원)\n구분\n2022년 (제12기 반기)\n2021년 (제11기)\n2020년(제10기)\n회계처리기준\nK-IFRS\nK-IFRS\nK-IFRS\n별도재무제표\n별도재무제표\n별도재무제표\n[유동자산]\n4,746,830\n2,814,680\n1,743,116\n\xa0현금및현금성자산\n87,976\n39,170\n20,460\n\xa0단기금융상품\n1,182,929\n450,000\n300,000\n\xa0당기손익-공정가치측정금융자산\n1,751,492\n850,040\n500,046\n\xa0매출채권및기타채권\n493,759\n366,338\n218,162\n\xa0재고자산\n1,093,667\n1,012,871\n645,960\n\xa0기타유동금융자산\n39,228\n23,984\n23,556\n\xa0기타유동자산\n9,119\n8,366\n7,067\n\xa0계약자산\n88,660\n63,911\n27,865\n[비유동자산]\n6,186,577\n3,088,732\n2,624,102\n\xa0장기금융상품\n5,187\n7\n7\n\xa0종속기업,관계기업및공동기업투자\n3,287,725\n541,389\n529,014\n\xa0투자부동산\n-\n-\n20,248\n\xa0유형자산\n2,536,647\n2,202,972\n1,734,019\n\xa0무형자산\n31,048\n32,152\n23,322\n\xa0사용권자산\n14,713\n17,884\n21,002\n\xa0매출채권및기타채권\n12,875\n4,428\n28,672\n\xa0순확정급여자산\n-\n3,572\n11,900\n\xa0기타비유동금융자산\n25,208\n26,920\n23,184\n\xa0기타비유동자산\n1,005\n1,227\n1,284\n\xa0계약자산\n202,581\n189,331\n168,892\n\xa0이연법인세자산\n69,588\n68,850\n62,558\n\xa0 \xa0 \xa0 \xa0 자산총계\n10,933,407\n5,903,412\n4,367,218\n[유동부채]\n2,150,777\n1,106,401\n588,727\n[비유동부채]\n1,936,965\n1,381,739\n783,650\n\xa0 \xa0 \xa0 \xa0 부채총계\n4,087,742\n2,488,140\n1,372,377\n[자본금]\n177,935\n165,413\n165,413\n[자본잉여금]\n5,672,425\n2,496,627\n2,496,627\n[기타포괄손익누계액]\n(13,999)\n(12,944)\n(10,198)\n[이익잉여금]\n1,009,304\n766,176\n342,999\n\xa0 \xa0 \xa0 \xa0자본총계\n6,845,665\n3,415,272\n2,994,841\n종속ㆍ관계ㆍ공동기업투자주식의 평가방법\n원가법\n원가법\n원가법\n기간\n2022년 1월~6월\n2021년 1월~12월\n2020년 1월~12월\n\xa0매출액\n1,014,962\n1,568,007\n1,164,777\n\xa0영업이익\n348,130\n536,495\n292,589\n\xa0법인세비용차감전이익\n324,882\n546,863\n280,889\n\xa0반기순이익\n243,127\n423,177\n250,969\n\xa0기본주당순이익 (원)\n3,560\n6,396\n3,793\n\xa0희석주당순이익 (원)\n3,553\n6,396\n3,793\n']"
